Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review.
<h4>Background</h4>Visceral leishmaniasis (VL) is an infectious parasitic disease caused by the species Leishmania (Leishmania) infantum in the Mediterranean Basin, the Middle East, Central Asia, South America, and Central America, and Leishmania (Leishmania) donovani in Asia and Africa....
Saved in:
Main Authors: | Karine Ferreira Lopes, Mariana Lourenço Freire, Silvane Maria Fonseca Murta, Edward Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-12-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0012757 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01) -
Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01) -
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
by: Pashupati Pokharel, et al.
Published: (2021-01-01) -
Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis
by: Maria Marta Figueiredo, et al.
Published: (2021-01-01) -
Visceral Leishmaniasis or Systemic Lupus Erythematosus Flare?
by: Sunny Garg, et al.
Published: (2012-01-01)